Theravance Biopharma (TBPH) to Release Earnings on Monday

Theravance Biopharma (NASDAQ:TBPH) is set to post its quarterly earnings results after the market closes on Monday, May 13th. Analysts expect Theravance Biopharma to post earnings of ($0.19) per share for the quarter. Individual interested in registering for the company’s earnings conference call can do so using this link.

Theravance Biopharma (NASDAQ:TBPH) last announced its quarterly earnings data on Monday, February 26th. The biopharmaceutical company reported ($0.17) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.15) by ($0.02). Theravance Biopharma had a negative return on equity of 19.31% and a negative net margin of 96.12%. The firm had revenue of $17.57 million during the quarter, compared to analysts’ expectations of $17.49 million. On average, analysts expect Theravance Biopharma to post $-1 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Theravance Biopharma Stock Performance

TBPH opened at $9.46 on Monday. The firm’s fifty day moving average is $9.10 and its 200 day moving average is $9.67. Theravance Biopharma has a fifty-two week low of $8.21 and a fifty-two week high of $11.98.

Analysts Set New Price Targets

TBPH has been the topic of several research analyst reports. BTIG Research began coverage on Theravance Biopharma in a research report on Friday, April 12th. They issued a “buy” rating and a $21.00 price objective on the stock. Evercore ISI downgraded Theravance Biopharma from an “outperform” rating to an “inline” rating in a research note on Monday, January 8th.

About Theravance Biopharma

Theravance Biopharma, Inc is a diversified biopharmaceutical company primarily focused on the discovery, development and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small molecule drugs designed to better meet patient needs. Its research is focused in the areas of inflammation and immunology.
In pursuit of its purpose, Theravance Biopharma applies insights and innovation at each stage of its business and utilizes its internal capabilities and those of partners around the world.